Skip to the page

Data / Form D filings / ResQ Pharma, Inc.

ResQ Pharma, Inc.: Form D filings

ResQ Pharma, Inc., a pharmaceuticals company in Glenview, IL, filed 5 Form D notices with the SEC between 2016 and 2024. The latest, on December 31, 2024, reports $99,999 sold of a $100,000 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2516 Waukegan Road, Suite 375, Glenview, IL, 60025
Phone
(312) 719-7702
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
United States
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1668333

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 31, 2024New notice$100,000$99,999$11Jul 27, 2024sec.gov
Jun 16, 2022New notice$300,000$205,501$94,4996May 13, 2022sec.gov
Sep 10, 2020New notice$2,000,000$1,020,000$980,0006Jun 22, 2020sec.gov
Sep 16, 2016New notice$764,500$739,500$25,00013Aug 31, 2016sec.gov
Mar 2, 2016New notice$325,000$325,0008Sep 17, 2015sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
August H. SchuppExecutive Officer, Director, Promoter
Dominic O'KeefeExecutive Officer, Director, Promoter
Guy WeinbergExecutive Officer, Director, Promoter
Joel TuneExecutive Officer, Director, Promoter

Every Form D from the week of Dec 30, 2024 · All recent filings in Illinois · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what ResQ Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.